Edgewise Therapeutics, Inc. (EWTX)
30.44
+0.78
(+2.63%)
USD |
NASDAQ |
Feb 27, 16:00
30.44
0.00 (0.00%)
After-Hours: 20:00
Edgewise Therapeutics EPS Diluted (Quarterly) : -0.4737 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Glaukos Corp. | -2.324 |
| Nuvalent, Inc. | -1.585 |
| Neurocrine Biosciences, Inc. | 1.482 |
| Omeros Corp. | -0.4666 |
| Agios Pharmaceuticals, Inc. | -1.852 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -50.22M |
| Total Expenses (Quarterly) | 50.22M |
| Enterprise Value | 2.697B |
| Earnings Yield | -5.36% |
| Normalized Earnings Yield | -5.362 |